Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constance O Okeke

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Medicine|June 15, 2017
Trabectome success factorsConstance O Okeke, Eydie Miller-Ellis, Mario Rojas, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 13, 2024
Latanoprostene Bunod 0.024% in Patients with Open-Angle Glaucoma Switched from Prior Pharmacotherapy: A Retrospective Chart ReviewConstance O Okeke, Nora Lee Cothran, Desirae A Brinkley, et al.
Ophthalmology|October 10, 2009
Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patientsConstance O Okeke, Harry A Quigley, Henry D Jampel, et al.
Ophthalmology|December 17, 2008
Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid studyConstance O Okeke, Harry A Quigley, Henry D Jampel, et al.
Ophthalmology|April 21, 2009
Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucomaDavid S Friedman, Constance O Okeke, Henry D Jampel, et al.
Ophthalmology and Therapy|October 9, 2020
Retrospective Chart Review on Real-World Use of Latanoprostene Bunod 0.024% in Treatment-Naïve Patients with Open-Angle GlaucomaConstance O Okeke, Eitan S Burstein, Valerie Trubnik, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Medicine|June 15, 2017
Trabectome success factorsConstance O Okeke, Eydie Miller-Ellis, Mario Rojas, et al.
Clinical Ophthalmology (Auckland, N.Z.)|February 13, 2024
Latanoprostene Bunod 0.024% in Patients with Open-Angle Glaucoma Switched from Prior Pharmacotherapy: A Retrospective Chart ReviewConstance O Okeke, Nora Lee Cothran, Desirae A Brinkley, et al.
Ophthalmology|October 10, 2009
Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patientsConstance O Okeke, Harry A Quigley, Henry D Jampel, et al.
Ophthalmology|December 17, 2008
Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid studyConstance O Okeke, Harry A Quigley, Henry D Jampel, et al.
Ophthalmology|April 21, 2009
Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucomaDavid S Friedman, Constance O Okeke, Henry D Jampel, et al.
Ophthalmology and Therapy|October 9, 2020
Retrospective Chart Review on Real-World Use of Latanoprostene Bunod 0.024% in Treatment-Naïve Patients with Open-Angle GlaucomaConstance O Okeke, Eitan S Burstein, Valerie Trubnik, et al.
Pageof 1